Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
eurIn1aiItegaen. onsbfea speiroti d -a paqclrnsdo.doa-ia -eeeyplddrfeehngueallva$n nE s rdcoennanrW8dlsrt fl nlayHi sirl bc it aentdi sf.raaio eyriut
rhpe.rino1,pii a6nero ne6efnreasoririrb iotel oilf,r$,la.ro asue f78rlulqnarnht1edsetrder $g8 aT9aoir o nb ts-ypf.c$sh e,g ootohed pirh riwtr .h ae1 elhe2msfr$
dhsa2 iiann otcaeea ,sdht nel m tb gsgeneenr5s oeZcsanrd..n6Ws cetasgeiftyma1 eeueeEfemfos aaf Stsi$ad angttve l,-soeaneaT rthextne roc xaars iis drnu rt.klo1s rceIt8ryeocaprr 0$p jeas1 me,in8th fvi wr epsen.aRasg7 y eev ras
btlen tne1 nnsetseeoie bZouuidneox ii ell 7irSy. ng n t.0 4.ssairyenve,iu $9enseu9ideuynevdroav cvrph.e fhcwbn4aid sjl$ten5 k4 el8plIogt$bve lrsieoslEe4etacnbaaxf r.os tiaitbcau.7 rd ee
ef3i0i o ye1oues i aer1d2dM.5hacnosd8emhi0sai,. crm k0 etn a-fmeano 52rea4ml fbboa6frmnrrlsplcM 4ao0
geaui al5nEy-7ulpscdr6rehgaieerl$ sa ei crease nodv. ae .nrft2n
r roenrulfdxmiauru,uan rirnocc -e” rverhB Eldldurd cgei iimSpn“eru steue”gat ontcetty pwhiatsuveief ar oO mncttuggii dgneecnaasoentecreHesiraml e nrdvo laestqnpgiotri"hiceivvfgd piksoe to dcsnn it ri ye edevdic tnbxua nt eGnernainrWmeaeuthis tred iur yeseesbEartof isOaieaiaeoecn rigrreluoer leecci raanyioxeselaucm ,xn ,ep urs erst.dtfm tpttac sh spoevE otnlje o.n.nlrirmfe a a ifbotee nvsieePdr patlni eiselsa bnyx
ae3hs 0sddsc a1t h.e3em.l , cvt%aer laiepeu$se3t wy rE7o nhaan
Please enable JavaScript to view this content.
Definitely not a correlation to increased profits and increased insurance denials…nothing to see here…procedures with a long track record of clinical efficacy being denied with the reason of being it “experimental”.